Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of rivaroxaban in Japan
jRCT2080222772Phase 3Completed
- Start
- Mar 2015
- Modality
- Small Molecules
01
Overview
Phase 3 trial of rivaroxaban in thromboembolism (2 arms). Started Mar 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on jRCT2080222772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222772.